MedTrace Logo

Evaluation of the Safety of the Medical Device Simeox®

NCT02061852 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-10-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether the medical device "simeox" is safe in the treatment of respiratory diseases, in comparison with traditional physiotherapy.

Conditions

  • Broncho-degenerative Disease
  • Chronic Obstructive Airway Disease
  • Cystic Fibrosis
  • Idiopathic Bronchiectasis
  • Ciliary Dyskinesia
  • Chronic Bronchitis

Interventions

DEVICE

Simeox

PROCEDURE

Physiotherapy

Sponsors & Collaborators

  • CEISO

    collaborator INDUSTRY

  • University Hospital, Marseille

    collaborator OTHER

  • Physio-Assist

    lead INDUSTRY

Principal Investigators

  • Martine Reynaud-Gaubert, Prof. · Hospital Marseille

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02061852 on ClinicalTrials.gov